Begin typing your search above and press return to search.
proflie-avatar
Login
exit_to_app
Democracy that banks on the electorate
access_time 28 March 2024 5:34 AM GMT
Lessons to learn from Moscow terror attack
access_time 27 March 2024 6:10 AM GMT
Gaza
access_time 26 March 2024 4:34 AM GMT
The poison is not in words, but inside
access_time 25 March 2024 5:42 AM GMT
A witchhunt, plain and simple
access_time 23 March 2024 9:35 AM GMT
DEEP READ
Schools breeding hatred
access_time 14 Sep 2023 10:37 AM GMT
Ukraine
access_time 16 Aug 2023 5:46 AM GMT
Ramadan: Its essence and lessons
access_time 13 March 2024 9:24 AM GMT
When ‘Jai Sree Ram’ becomes a death call
access_time 15 Feb 2024 9:54 AM GMT
exit_to_app
Homechevron_rightWorldchevron_rightChina's Sinovac made...

China's Sinovac made vaccine gets WHO's approval

text_fields
bookmark_border
Chinas Sinovac made vaccine gets WHOs approval
cancel

Geneva: The World Health Organization on Tuesday approved the Sinovac Covid-19 vaccine for emergency use.

With this, Sinovac becomes the second Chinese jab to receive the WHO's green light after Sinopharm was given the global body's official support on May 11.

In a statement, the UN health agency announced the approval for the Sinovac-CoronaVac Covid-19 vaccine for emergency use, giving countries, funders, procuring agencies and communities the assurance that it meets international standards for safety, efficacy and manufacturing.

The WHO recommended its use for people aged 18 and older in a two-dose schedule with a spacing of two to four weeks between shots.

Vaccine efficacy results showed that the vaccine prevented symptomatic disease in 51% of those vaccinated and prevented severe Covid-19 and hospitalisation in 100% of the studied population, the WHO said.

Following approval, Mariângela Simao, assistant director-general for access to health products at the WHO explained how the world desperately needs multiple COVID-19 vaccines to address the huge access inequity across the globe.

The authorisation of the Sinovac is now expected to pave the way for a wider rollout of the controversial shot in countries scrambling for a supply of immunizations.

In recent weeks, the WHO had sought more details regarding the safety of the shot and requested data about Sinovac's manufacturing process to assess whether it is compliant with WHO standards, according to people familiar with the matter.

Show Full Article
TAGS:WHOemergency useChina sinovac
Next Story